Latest News and Press Releases

Want to stay updated on the latest news?

Sign into Reader Account Create Reader Account

May 22, 2024 11:46 ET | Source: Syapse Holdings, Inc.

Syapse Expands Oncology Real-World Data Offerings with Introduction of Syapse Cohorts: Essentials

WEST CHESTER, Pa., May 22, 2024 (GLOBE NEWSWIRE) -- Syapse, a leading real-world oncology data company announced the launch of its latest real-world data offering: Syapse Cohorts: Essentials. This...
December 05, 2023 12:26 ET | Source: Syapse

Syapse and FDA Extend Collaboration to Advance the Use of Real-World Data (RWD) and Inform Regulatory Science in Oncology

Research collaboration between Syapse and the FDA Oncology Center of Excellence extended to assess fit-for-purpose RWD and explore the potential of RWE.
March 14, 2023 08:05 ET | Source: Syapse

Custom Research Presented at AMIA Informatics Summit Reveals Promising Findings for Healthcare Innovation

SAN FRANCISCO, March 14, 2023 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care,...
September 15, 2022 08:00 ET | Source: Syapse

Syapse Enters Collaboration with Merck Using Real-World Evidence to Better Understand Cancers

SAN FRANCISCO and NEW YORK, Sept. 15, 2022 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing...
August 31, 2022 08:00 ET | Source: Syapse

Syapse and Genesis Research Combine Forces to Offer Real-World Evidence Services and Data to Oncology Innovators

SAN FRANCISCO, Aug. 31, 2022 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today...
July 27, 2022 09:00 ET | Source: Syapse

Syapse Announces $35 Million Growth Investment with Innovatus Capital Partners to Expand Delivery of Real-World Evidence Through Syapse’s Learning Health Network

SAN FRANCISCO and NEW YORK, July 27, 2022 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing...
June 14, 2022 10:00 ET | Source: Syapse

Syapse and Pierian Announce Genomics Collaboration to Power Precision Oncology

SAN FRANCISCO, June 14, 2022 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company announced with Pierian®, a global leader in advanced clinical genomics technology, a new joint...
May 27, 2022 10:00 ET | Source: Syapse

Syapse Unveils Two New Studies on Use of Machine Learning on Real-World Data to Identify and Treat Cancer With Precision at ASCO 2022

SAN FRANCISCO, May 27, 2022 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care, today...
March 31, 2022 10:00 ET | Source: Syapse

Syapse Announces Changes to Board of Directors, Adding Michael Mentesana and Elevating Frank Williams to Chairman Role

SAN FRANCISCO, March 31, 2022 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care,...
March 22, 2022 10:00 ET | Source: Syapse

Main Line Health Collaborates with Syapse, Bringing Clinical Trial Opportunities to Patients with Cancer in Philadelphia Region

SAN FRANCISCO, March 22, 2022 (GLOBE NEWSWIRE) -- Syapse®, a leading real-world evidence company dedicated to extinguishing the fear and burden of serious diseases by advancing real-world care,...

Next Page keyboard_arrow_right